Literature DB >> 20804196

Discovery of novel 5-benzylidenerhodanine and 5-benzylidenethiazolidine-2,4-dione inhibitors of MurD ligase.

Nace Zidar1, Tihomir Tomasić, Roman Sink, Veronika Rupnik, Andreja Kovac, Samo Turk, Delphine Patin, Didier Blanot, Carlos Contreras Martel, Andréa Dessen, Manica Müller Premru, Anamarija Zega, Stanislav Gobec, Lucija Peterlin Masic, Danijel Kikelj.   

Abstract

We have designed, synthesized, and evaluated 5-benzylidenerhodanine- and 5-benzylidenethiazolidine-2,4-dione-based compounds as inhibitors of bacterial enzyme MurD with E. coli IC(50) in the range 45-206 μM. The high-resolution crystal structure of MurD in complex with (R,Z)-2-(3-[{4-([2,4-dioxothiazolidin-5-ylidene]methyl)phenylamino}methyl)benzamido)pentanedioic acid [(R)-32] revealed details of the binding mode of the inhibitor within the active site and provides a good foundation for structure-based design of a novel generation of MurD inhibitors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20804196     DOI: 10.1021/jm100285g

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  26 in total

1.  Molecular dynamics simulation and linear interaction energy study of D-Glu-based inhibitors of the MurD ligase.

Authors:  Andrej Perdih; Gerhard Wolber; Tom Solmajer
Journal:  J Comput Aided Mol Des       Date:  2013-08-30       Impact factor: 3.686

Review 2.  Resistance to antibiotics targeted to the bacterial cell wall.

Authors:  I Nikolaidis; S Favini-Stabile; A Dessen
Journal:  Protein Sci       Date:  2014-01-17       Impact factor: 6.725

3.  Virtual screening for potential inhibitors of bacterial MurC and MurD ligases.

Authors:  Tihomir Tomašić; Andreja Kovač; Gerhard Klebe; Didier Blanot; Stanislav Gobec; Danijel Kikelj; Lucija Peterlin Mašič
Journal:  J Mol Model       Date:  2011-06-12       Impact factor: 1.810

4.  Dual Inhibitor of MurD and MurE Ligases from Escherichia coli and Staphylococcus aureus.

Authors:  Tihomir Tomašić; Roman Sink; Nace Zidar; Anja Fic; Carlos Contreras-Martel; Andréa Dessen; Delphine Patin; Didier Blanot; Manica Müller-Premru; Stanislav Gobec; Anamarija Zega; Danijel Kikelj; Lucija Peterlin Mašič
Journal:  ACS Med Chem Lett       Date:  2012-06-27       Impact factor: 4.345

5.  Polyhalonitrobutadienes as Versatile Building Blocks for the Biotargeted Synthesis of Substituted N-Heterocyclic Compounds.

Authors:  Viktor A Zapol'skii; Ursula Bilitewski; Sören R Kupiec; Isabell Ramming; Dieter E Kaufmann
Journal:  Molecules       Date:  2020-06-21       Impact factor: 4.411

6.  New 5-ylidene rhodanine derivatives based on the dispacamide A model.

Authors:  Solene Guiheneuf; Ludovic Paquin; François Carreaux; Emilie Durieu; Thierry Roisnel; Laurent Meijer; Jean-Pierre Bazureau
Journal:  Mol Divers       Date:  2014-03-02       Impact factor: 2.943

7.  Synthesis of thiazolidine-2,4-dione derivatives: anticancer, antimicrobial and DNA cleavage studies.

Authors:  S Vijaya Laxmi; P Anil; G Rajitha; Asha Jyothi Rao; Peter A Crooks; B Rajitha
Journal:  J Chem Biol       Date:  2016-07-15

8.  Antimicrobial activity and cytotoxicity of some 2-amino-5-alkylidene-thiazol-4-ones.

Authors:  Marko Jukič; Aleksandra Đorđević; Jelena Lazarević; Martina Gobec; Andrija Šmelcerović; Marko Anderluh
Journal:  Mol Divers       Date:  2013-09-06       Impact factor: 2.943

9.  Isolation, characterization, anti-MRSA evaluation, and in-silico multi-target anti-microbial validations of actinomycin X2 and actinomycin D produced by novel Streptomyces smyrnaeus UKAQ_23.

Authors:  Kamal A Qureshi; Avinash D Bholay; Pankaj K Rai; Hamdoon A Mohammed; Riaz A Khan; Faizul Azam; Mariusz Jaremko; Abdul-Hamid Emwas; Piotr Stefanowicz; Mateusz Waliczek; Monika Kijewska; Ehab A Ragab; Medhat Rehan; Gamal O Elhassan; Md Jamir Anwar; Dinesh K Prajapati
Journal:  Sci Rep       Date:  2021-07-15       Impact factor: 4.379

10.  The binding mode of second-generation sulfonamide inhibitors of MurD: clues for rational design of potent MurD inhibitors.

Authors:  Mihael Simčič; Izidor Sosič; Milan Hodošček; Hélène Barreteau; Didier Blanot; Stanislav Gobec; Simona Golič Grdadolnik
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.